Search research articles
Contact Us
Filters
Showing results (41-50 of 100) with videos related to
Page
of 10
Sort By:
European Journal of Clinical Pharmacology
|
November 20, 2016
Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine
Michela Roberto, Adriana Romiti, Andrea Botticelli, et al.
Current Oncology Reports
|
February 24, 2024
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients
Alessandra Fabi, Alessandro Rossi, Edoardo Mocini, et al.
Journal of Personalized Medicine
|
August 27, 2021
Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
Alessia Romito, Sonia Bove, Ilaria Romito, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 20, 2026
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer
Alessandra Fabi, Elena Giordani, Elena Ricciardi, et al.
Endocrine
|
May 1, 2026
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practice
Sabrina Chiloiro, Maria Grazia Maratta, Simone Antonio De Sanctis, et al.
Clinical Breast Cancer
|
August 12, 2020
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach
Ida Paris, Danilo Di Giorgio, Luisa Carbognin, et al.
Clinical Breast Cancer
|
March 28, 2025
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study
Giovanna Garufi, Luca Mastrantoni, Noemi Maliziola, et al.
Scientific Reports
|
July 24, 2023
Computational reactive-diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib
Francesco Schettini, Maria Valeria De Bonis, Carla Strina, et al.
BMC Cancer
|
March 20, 2020
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study
Roberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, et al.
Reviews in Endocrine & Metabolic Disorders
|
May 29, 2026
Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review
Sabrina Chiloiro, Simone Antonio De Sanctis, Bianca Parente, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 100) with videos related to
Sort By:
Page
of 10
European Journal of Clinical Pharmacology
|
November 20, 2016
Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine
Michela Roberto, Adriana Romiti, Andrea Botticelli, et al.
Current Oncology Reports
|
February 24, 2024
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients
Alessandra Fabi, Alessandro Rossi, Edoardo Mocini, et al.
Journal of Personalized Medicine
|
August 27, 2021
Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
Alessia Romito, Sonia Bove, Ilaria Romito, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 20, 2026
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer
Alessandra Fabi, Elena Giordani, Elena Ricciardi, et al.
Endocrine
|
May 1, 2026
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practice
Sabrina Chiloiro, Maria Grazia Maratta, Simone Antonio De Sanctis, et al.
Clinical Breast Cancer
|
August 12, 2020
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach
Ida Paris, Danilo Di Giorgio, Luisa Carbognin, et al.
Clinical Breast Cancer
|
March 28, 2025
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study
Giovanna Garufi, Luca Mastrantoni, Noemi Maliziola, et al.
Scientific Reports
|
July 24, 2023
Computational reactive-diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib
Francesco Schettini, Maria Valeria De Bonis, Carla Strina, et al.
BMC Cancer
|
March 20, 2020
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study
Roberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, et al.
Reviews in Endocrine & Metabolic Disorders
|
May 29, 2026
Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review
Sabrina Chiloiro, Simone Antonio De Sanctis, Bianca Parente, et al.
Page
of 10